Xconomy’s Digital Events →
Scribe Therapetics co-founder and vice president of platform Brett Staahl (left) and co-founder and CEO Benjamin Oakes (right). Photo by Scribe Therapeutics.
Sponsored · Video
A Fireside Chat with Biocom President & CEO Joe Panetta
Sponsored · Whitepaper
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.